Jul. 7 at 6:49 AM
$NEUP SCANCELL without funding to start PHASE3 for Ibsci for Melanoma,so what? Co has Deep pocketed shareholders for what I have read on message boards and huge Ip, asset (3 platforms) but without fresh Money shareholders lose their investment and Company closes doors regardless of science.
The same for Neuphoria, without Merck partnership if confirmed, It could become a Shell for NASDAQ requirements and delisted, so It needs to merge, acquire or liquidate what Is due to holders.
So if no fresh funding from AIM London or advances by 2 MAIN holders, SCANCELL forced to merge with Neuphoria or other 3rd party. Talks are advanced, both need one each other, I don't believe we Will wait for 30 days but a few weeks.
Neup Bod has a fiduciary duty to shareholders, After rejecting 5.25 9 months ago, we have not only lose the TIME MONEY of our investment but we are trading close to historical all time lows. I Hope Bod to deliver a valuation of Neup of at least 6 CVRs included when deal done.
